We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global In Vitro Toxicology Testing Market

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The global In Vitro Toxicology Testing Market was valued at USD 6.1 billion in 2016 and is projected to reach USD 15.60 billion by 2025, growing at a CAGR of 11.0% from 2017 to 2025.

In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.

Sample Infographics:




Market Dynamics:
1. Market Drivers
1.1 Increasing ethical issues about animal testing
1.2 Growing stability in in-vitro technologies
1.3 Growing funds in R&D Department

2. Market Restraints
2.1 Resistance from regulatory bodies due to safety concerns and risks
2.2 Less assurance of in vivo stability after in vitro product transfer
2.3 Lack of in vitro models

Market Segmentation:
1. Global In Vitro Toxicology Testing Market, by Toxicity end point and test results:
1.1 ADME (Absorption, Distribution, Metabolism, and Excretion)
1.2 Skin Irritation, Corrosion, and Sensitization
1.3 Genotoxicity Testing
1.4 Cytotoxicity Testing
1.5 Ocular Toxicity
1.6 Organ Toxicity
1.7 Phototoxicity Testing
1.8 Dermal Toxicity
1.9 Carcinogenicity
1.10 Neurotoxicity
1.11 Other Toxicity Endpoints & Tests

2. Global In Vitro Toxicology Testing Market, by Products and Services:
2.1 Assays
2.1.1 Bacterial Toxicity Assays
2.1.2 Enzyme Toxicity Assays
2.1.3 Cell-Based Elisa and Western Blots
2.1.4 Receptor-Binding Assays
2.1.5 Tissue Culture Assays
2.1.6 Other Assays
2.2 Services
2.3 Reagents and labware

3. Global In Vitro Toxicology Testing Market, by Industry:
3.1 Pharmaceutical and Biopharmaceutical Industry
3.2 Cosmetics and Household Products Industry
3.3 Food Industry
3.4 Chemical Industry

4. Global In Vitro Toxicology Testing Market, by Method:
4.1 Cellular Assays
4.2 Biochemical Assays
4.3 EX Vivo Models

5. Global In Vitro Toxicology Testing Market, by Technology:
5.1 Cell Culture Technologies
5.2 High-Throughput Technologies
5.3 Cellular Imaging Technologies
5.4 Toxicogenomics

6. Global In Vitro Toxicology Testing Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. SGS S.A.
2. Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
3. Bio-Rad Laboratories, Inc.
4. Qiagen N.V.
5. GE Healthcare
6. Eurofins Scientific Se
7. Merck KGaA
8. Thermo Fisher Scientific, Inc
9. Charles River Laboratories International, Inc.
10. Catalent, Inc.
11. Cyprotex PLC (A Subsidiary of Evotec Ag)
12. Promega Corporation
13. Gentronix Limited
14. Ascendance Biotechnology, Inc.
15. MB Research Laboratories

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the In Vitro Toxicology Testing Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

1 INTRODUCTION OF GLOBAL IN VITRO TOXICOLOGY TESTING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY END POINT AND TEST RESULTS
5.1 Overview
5.2 ADME (Absorption, Distribution, Metabolism, and Excretion)
5.3 Skin Irritation, Corrosion, and Sensitization
5.4 Genotoxicity Testing
5.5 Cytotoxicity Testing
5.6 Ocular Toxicity
5.7 Organ Toxicity
5.8 Phototoxicity Testing
5.9 Dermal Toxicity
5.10 Carcinogenicity
5.11 Neurotoxicity
5.12 Other Toxicity Endpoints & Tests

6 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCTS AND SERVICES
6.1 Overview
6.2 Assays
6.2.1 Bacterial Toxicity Assays
6.2.2 Enzyme Toxicity Assays
6.2.3 Cell-Based Elisa and Western Blots
6.2.4 Receptor-Binding Assays
6.2.5 Tissue Culture Assays
6.2.6 Other Assays
6.3 Services
6.4 Reagents and labware

7 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
7.1 Overview
7.2 Pharmaceutical and Biopharmaceutical Industry
7.3 Cosmetics and Household Products Industry
7.4 Food Industry
7.5 Chemical Industry

8 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
8.1 Overview
8.2 Cellular Assays
8.3 Biochemical Assays
8.4 EX Vivo Models

9 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
9.1 Overview
9.2 Cell Culture Technologies
9.3 High-Throughput Technologies
9.4 Cellular Imaging Technologies
9.5 Toxicogenomics

10 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

11 GLOBAL IN VITRO TOXICOLOGY TESTING MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 SGS S.A.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Covance, Inc.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Bio-Rad Laboratories, Inc
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Qiagen N.V.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 GE Healthcare
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 Eurofins Scientific SE
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 Merck KGaA
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Thermo Fisher Scientific, Inc
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Charles River Laboratories International
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 Catalent, Inc.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

12.11 Cyprotex PLC
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments

12.12 Promega Corporation
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments

12.13 Gentronix Limited
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments

12.14 Ascendance Biotechnology, Inc.
12.14.1 Overview
12.14.2 Financial Performance
12.14.3 Product Outlook
12.14.4 Key Developments

12.15 MB Research Laboratories
12.15.1 Overview
12.15.2 Financial Performance
12.15.3 Product Outlook
12.15.4 Key Developments

13 Appendix
13.1 Related Reports

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved